It can be seen from analysis on major blood grouping analyzer-related patent applications published in the 3 years from 2018 to 2021 that benefited from the basically stable original technologies of the industry; domestic enterprises have continuously increased R&D inputs, constantly improved technical innovation capability, made breakthroughs in many technologies, and developed a batch of core components of instruments with independent intellectual property rights through follow-on R&D strategy.

China plans to accelerate the establishment of a tiered healthcare delivery system, focusing on strengthening primary-level medical capacity to manage common and chronic diseases such as hypertension and diabetes, authorities said.

Peng Yang, global vice president of Danaher and president of Danaher China, recently said in an exclusive interview with a reporter from 21st Century Business Herald during the J.P.Morgan Global Healthcare Conference, Shanghai Forum, "We believe China Will Become the World's Largest IVD Market ."

CTK Biotech said on Tuesday that its OnSite COVID-19 Ag Self Test has been CE marked.

Pacific Biosciences said after the close of the market on Tuesday that its third quarter revenues rose 83 percent, driven by growth in sequencing instruments and consumables.

Thermo Fisher Scientific said on Monday that it has acquired Belgium-based PharmaFluidics, the developer of the μPAC range of microchip-based chromatography columns.

Bruker reported after the close of the market Monday that revenues in the third quarter rose 19 percent year over year.

Hologic reported after the close of the market on Monday that its fiscal fourth quarter revenues fell 2 percent year over year, driven by a drop in molecular diagnostic and COVID-19 assay sales.

Some of the neurological symptoms associated with menopause are similar to early signs of dementia. The ability of MHT to alleviate such symptoms in some women has led scientists to question whether a link exists between specific hormone levels and dementia.

The US Food and Drug Administration on Thursday said it has granted Emergency Use Authorization for Detect's over-the-counter, at-home SARS-CoV-2 test.

A few days ago, EUROIMMUN (PerkinElmer) formally completed the acquisition of British diagnostic company Immunodiagnostic Systems (IDS). In the future, IDS, as a new member of the PerkinElmer Group, will cooperate closely with EUROIMMUN in the fields of R&D, production, and sales.

CareDx reported after the close of the market on Thursday that its third quarter revenues rose 42 percent year over year, thanks largely to a 46 percent increase in testing service revenues during the quarter.